Laval, Canada

Mohamed Atfani

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 10.3

ph-index = 5

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mohamed Atfani

Introduction

Mohamed Atfani is a notable inventor based in Laval, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for medical applications. With a total of seven patents to his name, Atfani's work focuses on innovative methods for delivering therapeutic agents.

Latest Patents

Among his latest patents is a groundbreaking invention related to methods, compounds, compositions, and vehicles for delivering 3-amino-1-propanesulfonic acid (3APS). This invention is particularly relevant for its potential applications in treating Alzheimer's disease. The invention encompasses compounds that can yield or generate 3APS, either in vitro or in vivo. Preferred compounds include amino acid prodrugs of 3APS, which are designed for effective delivery in human subjects.

Career Highlights

Throughout his career, Atfani has worked with several prominent companies, including Bellus Health Inc. and Bhi Limited Partnership. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.

Collaborations

Atfani has collaborated with notable colleagues in his field, including Xianqi Kong and Benoit Bachand. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

In summary, Mohamed Atfani is a distinguished inventor whose work in pharmaceutical innovations has the potential to impact the treatment of Alzheimer's disease significantly. His contributions through patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…